Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First RelapseEric L. Sievers, Edward A. Stadtmauer, Elihu H. Estey et al.|Journal of Clinical Oncology|2001Cited by 898
Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33‐positive acute myeloid leukemia in first recurrenceRichard A. Larson, Frederick R. Appelbaum, Eric L. Sievers et al.|Cancer|2005Cited by 459